Closed · W81XWH-10-LCRP-LCEDCC · CFDA 12.420 · Discretionary
DOD Lung Cancer Early Detection Clinical Consortium Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- December 7, 2010
- Close date
- 1
- Expected awards
The verdict
DOD Lung Cancer Early Detection Clinical Consortium Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 1
- expected award
- 12.420
- CFDA program
Archived opportunity record
DOD Lung Cancer Early Detection Clinical Cons… is closed (last close December 7, 2010). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed December 7, 2010
Est. Total Funding
$13,500,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
The LCRP Early Detection Clinical Consortium Award mechanism is being offered for the first time in Fiscal Year 2010. The intent of the award is to fund clinical studies focused on characterizing, developing, and/or improving early detection modalities for lung cancer. The award is designed to bring together populations of military beneficiaries at high risk for developing lung cancer and lung cancer patients from the specified military treatment facilities (MTFs) listed in Section B.2 with the patient populations and research expertise of highly qualified civilian scientists at outstanding organizations. At the time of award completion, it is anticipated that the recipient will have established a strong infrastructure for an early detection program in order to continue clinical studies that will lead to improved patient outcomes. Projects should be militarily relevant, have well defined objectives, should control for confounders, have a patient population that will provide a sample size of sufficient statistical power, and be capable of producing results that are likely to change clinical practice for early detection of lung cancer. Studies involving non-military patient populations must describe how they pertain to the targeted population (i.e. Armed Forces and/or the US veteran population). Studies proposed for this multi-institutional consortium effort can include small randomized or pilot clinical trials as well as large, randomized clinical trials. All projects shall be limited to clinical research and clinical trials. Animal studies are excluded from consideration.
Catch-all / unrestricted eligibility mark · W81XWH-10-LCRP-LCEDCC
Grants.gov marks DOD Lung Cancer Early Detection Clinical Cons… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DOD Lung Cancer Early Detection Clinical Cons… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |